Novo Nordisk's pricing methods from the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of rate gouging, stating the stark distinction between U.S. price ranges and people in Europe and copyright.In October 2024, Novo Nordisk released a research on scientific journal Character about a novel glucose-s